City Therapeutics
Drug Discovery

City Therapeutics news and milestones

City Therapeutics: 8 headlines on record, 4 headlines in the last 90 days. Its story counts 2 milestones.

Data updated Nov 22, 2026 · Back to the company report
8Headlines
4In 90 days
2Milestones

Headlines

Sep 252026
News · Renaissance Capital
City Therapeutics, a Phase 1 biotech developing RNA interference therapies for thromboembolic diseases, filed on Thursday with the SEC to raise up to $100 million in an initial p…
Sep 242026
News · 24/7 Wall St.
City Therapeutics has filed its S-1 to list on Nasdaq, with Goldman Sachs, Jefferies, Stifel and Oppenheimer running the books. Terms and deal size are not set yet, so the price…
Sep 242026
News · marketwatch.com
Sep 242026
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

City Therapeutics, News. Alion, Nov 22, 2026. https://alion.io/company/citytx/news

.json · .md · CC BY-SA 4.0